| |
| | Patent 6,962,787 |
 | | EDRF is expressed in hematopoietic cells of the erythroid and megakaryocyte/platelet lineage, in spleen, bone marrow and blood. |
 | | EDRF is expressed in bipotent cells capable of proceeding through erythroid or megakaryocyte lineages or E/Meg cells, blast-forming unit (BFU-E) cells, colony-forming unit (CPU-E) cells, proerythroblasts (rubriblasts), early normoblasts (basophilic erythroblasts or prorubricytes), intermediate erythroblasts (rubricytes or polychromatophilic erythroblasts), late normoblasts (metarubricytes or orthochromatophilic erythroblasts), including haemoglobin-positive normoblasts and reticulocytes, i.e. |
 | | A reduction in levels of EDRF in the sample is indicative of TSE infection (or a TSE disease condition) in a subject. |
| www.pharmcast.com /Patents100/Yr2005/Nov2005/110805/6962787_Spongiform110805.htm (4144 words) |
|